Portage Biotech Net Income
| PRTGDelisted Stock | USD 6.08 0.54 9.75% |
As of the 7th of February, Portage Biotech holds the Coefficient Of Variation of (2,589), risk adjusted performance of (0.02), and Variance of 53.51. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Portage Biotech, as well as the relationship between them. Please check Portage Biotech risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Portage Biotech is priced some-what accurately, providing market reflects its current price of 6.08 per share. Given that Portage Biotech has information ratio of (0.05), we recommend you to check out Portage Biotech's recent market performance to make sure the company can sustain itself at a future point.
Portage Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Portage Biotech's valuation are provided below:Portage Biotech does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Portage |
Search Suggestions
| PR | Permian Resources | Company |
| PRIF-PG | Priorityome Fund | Company |
| PRAPX | Pimco Total Return | Mutual Fund |
| PRB | Van Eck | ETF |
| PRA | PRA | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Portage Biotech reported net income of (6.77 Million). This is 101.98% lower than that of the Biotechnology sector and 109.66% lower than that of the Health Care industry. The net income for all United States stocks is 101.19% higher than that of the company.
Portage Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Portage Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Portage Biotech could also be used in its relative valuation, which is a method of valuing Portage Biotech by comparing valuation metrics of similar companies.Portage Biotech is currently under evaluation in net income category among its peers.
Portage Fundamentals
| Return On Equity | -5.42 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 9.86 M | |||
| Shares Outstanding | 2.28 M | |||
| Shares Owned By Insiders | 60.57 % | |||
| Shares Owned By Institutions | 4.16 % | |||
| Number Of Shares Shorted | 36.16 K | |||
| Price To Book | 9.34 X | |||
| EBITDA | (7.38 M) | |||
| Net Income | (6.77 M) | |||
| Cash And Equivalents | 21.18 M | |||
| Cash Per Share | 1.25 X | |||
| Total Debt | 3.05 M | |||
| Current Ratio | 11.73 X | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (5.46 M) | |||
| Short Ratio | 0.88 X | |||
| Earnings Per Share | (5.72) X | |||
| Target Price | 140.0 | |||
| Beta | 0.64 | |||
| Market Capitalization | 15.52 M | |||
| Total Asset | 2.23 M | |||
| Retained Earnings | (245.45 M) | |||
| Working Capital | 1.12 M | |||
| Net Asset | 2.23 M |
About Portage Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Portage Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Portage Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Portage Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Portage Stock
If you are still planning to invest in Portage Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Portage Biotech's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |